Weikang Pharmaceutical (300878.SZ) announced its 2023 annual results, with a net loss of 8.038,600 yuan, a year-on-year profit to loss

Weikang Pharmaceutical (300878.SZ) released its 2023 annual report. The company achieved revenue of 520 million yuan during the reporting period, a decrease of 2.41% over the previous year. The net loss attributable to shareholders of the listed company was RMB 8,038,600, a year-on-year change of profit to loss. The net loss attributable to shareholders of the listed company after deducting non-recurring profit and loss was 25.217,500 yuan, a year-on-year profit to loss. Basic earnings per share - 0.06 yuan/share, and it is proposed to distribute a cash dividend of 2.50 yuan (tax included) for every 10 shares to all shareholders.

Zhitong FinanceApr 28 20:13

Express News | Weikang Pharmaceutical: Net profit of 243.35 million yuan in the first quarter decreased 11.6% year on year

BreakingsApr 28 17:48

Here's Why We're Wary Of Buying VICOM's (SGX:WJP) For Its Upcoming Dividend

Yahoo FinanceApr 27 10:35

Dajia Weikang (301126.SZ) announced first-quarter results, net profit of 19.436,900 yuan, an increase of 27.14%

Dajia Weikang (301126.SZ) released its report for the first quarter of 2024. During the reporting period, it achieved revenue of 1.28 billion yuan, an increase of 46.06% over the previous year. Net profit attributable to shareholders of listed companies was 19.4369 million yuan, an increase of 27.14% over the previous year. Net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 19.3812 million yuan, an increase of 31.45% over the previous year.

Zhitong FinanceApr 22 20:16

Express News | The Zhejiang Securities Regulatory Bureau ordered corrections and issued a warning letter against Zhejiang Weikang Pharmaceutical

BreakingsApr 22 16:54

Shareholders May Be More Conservative With VICOM Ltd's (SGX:WJP) CEO Compensation For Now

Yahoo FinanceApr 18 06:15